MITOTANE for Adrenocortical carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 461 adverse event reports in the FDA FAERS database where MITOTANE was used for Adrenocortical carcinoma.
Most Reported Side Effects for MITOTANE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 210 | 20.8% | 6 | 37 |
| Fatigue | 205 | 20.3% | 10 | 42 |
| Off label use | 154 | 15.2% | 11 | 25 |
| Diarrhoea | 123 | 12.2% | 3 | 22 |
| Vomiting | 97 | 9.6% | 6 | 29 |
| Drug ineffective | 86 | 8.5% | 10 | 25 |
| Decreased appetite | 77 | 7.6% | 5 | 25 |
| Adrenal insufficiency | 76 | 7.5% | 2 | 18 |
| Dizziness | 76 | 7.5% | 2 | 12 |
| Asthenia | 70 | 6.9% | 3 | 24 |
| Malignant neoplasm progression | 61 | 6.0% | 15 | 14 |
| Neutropenia | 48 | 4.8% | 4 | 7 |
| Febrile neutropenia | 42 | 4.2% | 2 | 4 |
| Headache | 42 | 4.2% | 1 | 11 |
| Anaemia | 41 | 4.1% | 2 | 12 |
Other Indications for MITOTANE
Adrenal gland cancer (250)
Product used for unknown indication (88)
Metastases to lung (25)
Metastases to liver (23)
Cushing's syndrome (22)
Metastatic neoplasm (22)
Adjuvant therapy (18)
Chemotherapy (10)
Neoplasm malignant (10)
Adrenal gland cancer metastatic (9)
Other Drugs Used for Adrenocortical carcinoma
ETOPOSIDE (263)
CISPLATIN (219)
DOXORUBICIN (219)
PEMBROLIZUMAB (56)
CARBOPLATIN (48)
CABOZANTINIB S-MALATE (27)
NIVOLUMAB (27)
CAPECITABINE (22)
GEMCITABINE (22)
IPILIMUMAB (21)